Treatment of Severe Anxiety
For severe anxiety disorders, the recommended first-line treatment is a combination of Cognitive Behavioral Therapy (CBT) and an SSRI or SNRI medication, initiated simultaneously to maximize treatment effectiveness and improve morbidity, mortality, and quality of life outcomes. 1
Pharmacological Treatment
First-Line Medications
Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Medication Monitoring
- Assess response after 4-6 weeks of medication
- Continue effective medication for at least 6-12 months after symptom remission
- Taper gradually when discontinuing to avoid withdrawal symptoms 1
- Periodically reevaluate the long-term usefulness of the medication 2
Common Side Effects to Monitor
- SSRIs/SNRIs: Diaphoresis, dry mouth, abdominal discomfort, nausea, dizziness, headache, insomnia, sexual dysfunction
- Serious but uncommon effects: Suicidal thinking (especially in young patients), serotonin syndrome, abnormal bleeding 1
Psychotherapeutic Approaches
- Cognitive Behavioral Therapy (CBT)
Treatment Algorithm
Initial Assessment
- Determine severity of anxiety and functional impairment
- Screen for comorbidities (approximately one-third of patients have comorbid psychiatric disorders) 1
Treatment Initiation
- For severe anxiety: Begin both CBT and SSRI/SNRI simultaneously 1
- For mild anxiety with minimal impairment: CBT alone may be sufficient initially
Treatment Adjustment
Special Populations
Children and Adolescents (7-17 years)
Elderly Patients
- Start on lower doses and titrate more slowly 1
Patients with Hepatic/Renal Impairment
- Require dose adjustments and careful monitoring 1
Pregnancy and Lactation
- Use SSRIs with caution when benefits outweigh risks 1
Lifestyle Modifications
Recommend the following evidence-based lifestyle changes to augment pharmacological and psychological treatments:
- Establish consistent morning routine
- Regular exercise
- Good sleep hygiene
- Limited screen time before bed and after waking
- Time in nature
- Mindfulness and meditation practices 1
Common Pitfalls to Avoid
Benzodiazepines
Inadequate Treatment Duration
- Premature discontinuation before 6-12 months after symptom remission increases relapse risk 1
Overlooking Comorbidities
- Failure to address comorbid conditions may lead to treatment resistance 1
Insufficient Dose or Duration
- Anxiety disorders may require higher doses and longer treatment duration than depression 3